Showing results (421-430 of 440) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|October 23, 2014
High-dose rifapentine with moxifloxacin for pulmonary tuberculosisAmina Jindani, Thomas S Harrison, Andrew J Nunn, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
The New England Journal of Medicine|September 2, 2022
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant TuberculosisFrancesca Conradie, Tatevik R Bagdasaryan, Sergey Borisov, et al.
The Journal of Antimicrobial Chemotherapy|March 9, 2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanidAnna Bateson, Julio Ortiz Canseco, Timothy D McHugh, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
Pageof 44